Status:
COMPLETED
e-Cigarette - DNA Adducts
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Smoking
Cigarette Smoking
Eligibility:
All Genders
18+ years
Brief Summary
This study will examine the level of toxicity of e-cigarette use compared to smokers and nonsmokers including inflammation markers, toxicant and carcinogen exposure. Additionally, the study will look ...
Detailed Description
In this observational study, e-cigarette users, smokers, and non-users of e-cigarette or tobacco products (up to 134 per group) will be recruited from the Minneapolis-St. Paul area. This research will...
Eligibility Criteria
Inclusion
- Good physical health with no unstable medical conditions; Able to provide written informed consent; Stable and good mental health;
- Meet criteria for 1 of three groups:
- Regular smokers confirmed by CO;
- E-cigarette users (exclusive e-cigarette use for 3 months); Non-Tobacco Users
- Non-smokers
Exclusion
- Unstable medical condition Not willing to attend visits
Key Trial Info
Start Date :
July 11 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT03284632
Start Date
July 11 2017
End Date
June 1 2021
Last Update
November 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55414